Boehringer Ingelheim
Pascal Fayard is a seasoned professional in the animal health sector, currently serving as Senior Director of Business Development and Licensing in the Animal Health Division at Boehringer Ingelheim since January 2017. Prior experience includes various leadership roles at Merial, a Sanofi Company, spanning over a decade, where positions included Director of Business Development for EMEA and Marketing Director for both Pet Therapeutics and Pets and Equine Vaccines. Pascal's career began at Merial Japan and continued through reputable organizations like Nippon Sanofi and Rhône-Poulenc Japan, accumulating expertise in marketing, regulatory affairs, and veterinary practices. Educational credentials include an Executive MBA from ESCP Business School and a Doctor in Veterinary Medicine from Ecole nationale vétérinaire de Lyon.
This person is not in any teams
This person is not in any offices
Boehringer Ingelheim
116 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.